Sagimet Biosciences, Inc. (SGMT)
5.06
-0.09
(-1.75%)
USD |
NASDAQ |
Feb 13, 16:00
5.06
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences EPS Diluted (Quarterly) : -0.3976 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.91M |
| Total Expenses (Quarterly) | 12.91M |
| Enterprise Value | 46.33M |
| Earnings Yield | -35.34% |
| Normalized Earnings Yield | -35.34 |